tyrosine and Prosthesis Durability

tyrosine has been researched along with Prosthesis Durability in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Damron, TS; DeBoyace, SD; Ee, JS; Margulies, BS; Parsons, AM; Policastro, CG1
Anderson, HV; Assali, AR; Fujise, K; Ghani, M; Rosales, OR; Schroth, G; Sdringola, S; Smalling, RW; Westbrook, LA1
Hetzer, R; Koster, A; Kuppe, H; Loebe, M; Mertzlufft, F1

Other Studies

3 other study(ies) available for tyrosine and Prosthesis Durability

ArticleYear
Functionally deficient mesenchymal stem cells reside in the bone marrow niche with M2-macrophages and amyloid-β protein adjacent to loose total joint implants.
    Journal of orthopaedic research : official publication of the Orthopaedic Research Society, 2015, Volume: 33, Issue:5

    Topics: Aged; Amyloid beta-Protein Precursor; Arthroplasty, Replacement; Bone Marrow; Femur; Humans; Macrophages; Mesenchymal Stem Cells; Middle Aged; Osteogenesis; Prosthesis Failure; Reoperation; tau Proteins; Tyrosine

2015
Timing of coronary stent thrombosis in patients treated with prophylactic tirofiban.
    The Journal of invasive cardiology, 2000, Volume: 12, Issue:9

    Topics: Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Disease; Female; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prosthesis Failure; Retrospective Studies; Stents; Time Factors; Tirofiban; Tyrosine

2000
Cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia II and impaired renal function using heparin and the platelet GP IIb/IIIa inhibitor tirofiban as anticoagulant.
    The Annals of thoracic surgery, 2000, Volume: 70, Issue:6

    Topics: Cardiopulmonary Bypass; Drug Therapy, Combination; Female; Heart Valve Prosthesis Implantation; Heparin; Hirudins; Humans; Kidney Function Tests; Middle Aged; Mitral Valve; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Postoperative Care; Prosthesis Failure; Recombinant Proteins; Reoperation; Thrombocytopenia; Tirofiban; Tyrosine

2000